• Sentimag ad x
  • SSO C SSO Digital Assets Web REG x
  • SSO Mobile App Website Top 1150x135 Banner

ADVERTISEMENT

Speaking of SurgOnc®

Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).

The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals of Surgical Oncology.

Once a month, Dr. Greene will interview authors and leading experts in surgical oncology. Speaking of SurgOnc® episodes will be available on this page and wherever you listen to your favorite podcasts, including Apple Podcasts, Spotify, Stitcher. iHeartRadio and TuneIn

2000x2000 Speaking of SurgOnc podcast scaled

Episode 27: “Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control”

November 9, 2021

In this episode of Speaking of SurgOnc, Rick Greene, MD and Kristin E. Rojas, MD, discuss the implementation of an opioid-sparing multimodal analgesia protocol for lumpectomy patients for pain management without a routine opioid prescription. Dr. Rojas is author of the article, “Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control.”

Dr. Rojas is Assistant Professor of Surgery at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.

Episode 26: “Impact of the COVID-19 Pandemic on Cancer Clinical Trials”

October 12, 2021

In this episode of Speaking of SurgOnc®, Rick Greene, MD, and Judy Boughey, MD, discuss the impact of COVID-19 on US clinical research at the local, cooperative group, and national level. Dr. Boughey is the author of the article, “Impact of the COVID-19 Pandemic on Cancer Clinical Trials.”

Dr. Judy Boughey is Professor of Surgery in Division of Breast and Melanoma Surgical Oncology, Department of Surgery at Mayo Clinic, Rochester, MN.

Episode 25: “Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?”

August 10, 2021

Rick Greene, MD, and Elisa Port, MD, discuss surgeon adherence to NCCN guidelines and patterns of testing in newly diagnosed breast cancer patients. Dr. Port is author of, “Adherence to NCCN Guidelines for Genetic Testing in Breast Cancer Patients: Who Are We Missing?”

Dr. Port is Chief of Breast Surgery and Director of the Dubin Breast Center, Mount Sinai Hospital, and  Professor of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.

Episode 24: “Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines”

July 13, 2021

Rick Greene, MD and Nancy Cho, MD discuss the impact of the 2015 American Thyroid Association guideline change on clinical practice in low-risk differentiated thyroid cancer, specifically regarding the rate of completion thyroidectomy. Dr. Cho is author of the article, “Completion Thyroidectomy is Less Common Following Updated 2015 American Thyroid Association Guidelines.”

Dr. Cho is Associate Surgeon, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, and Assistant Professor of Surgery, Harvard Medical School, Boston, MA.

Episode 23: “Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons”

June 15, 2021

Rick Greene, MD, and Courtney Balentine, MD, discuss race and gender disparities in the time from initial diagnosis of hyperparathyroidism to treatment with parathyroidectomy. Dr. Balentine is author of, “Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons.”

Dr. Balentine is Assistant Professor of General and Endocrine Surgery, and Co-Director of the UTSW Surgical Center for Outcomes, Implementation and Novel Interventions (S-COIN), University of Texas Southwestern and VA North Texas Healthcare System, Dallas, TX.

Episode 22: “Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer”

May 20, 2021

Rick Greene, MD and Vivian Strong, MD discuss factors associated with quality-of-life recovery after gastrectomy. Dr. Strong is author of “Longitudinal Analysis of Quality-of-Life Recovery After Gastrectomy for Cancer.”

Dr. Strong is the Iris Cantor Endowed Chair and Attending Surgeon, Memorial Sloan Kettering Cancer Center; Professor of Surgery and Associate Dean, Weill Cornell Medical College of Cornell University; and Vice Chair of Surgery for Surgical Innovations and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY.

Episode 21: “Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma”

March 9, 2021

Rick Greene, MD, and Melissa Hogg, MD, discuss the relationship of serum CA19-9 to other markers of response, and the related thresholds correlating to outcomes, following neoadjuvant therapy for pancreatic adenocarcinoma. Dr. Hogg is author of the article, “Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.”

Dr. Hogg is the Director of HPB Surgery and Director of Robotic Training for Grainger Lab at the Northshore University Healthsystem, Chicago, IL.

Episode 20: “Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change”

February 9, 2021

Rick Greene, MD, and Ken Tanabe, MD, discuss the need for surgical oncologists to remain focused on providing optimal care for our cancer patients while managing the demands that the COVID-19 pandemic continues to impose. Dr. Tanabe is author of, “Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change.”

Dr. Tanabe is a Professor of Surgery at Harvard Medical School and Chief, Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital. Dr. Tanabe is also Deputy Editor of the Annals of Surgical Oncology.

Episode 19: “Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade”

January 14, 2021

Rick Greene, MD and Charlotte Ariyan, MD, PhD, discuss survival outcomes in patients with metastatic melanoma who were selected for surgery following checkpoint blockade. Dr. Ariyan is author of, “Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.”

Dr. Ariyan is Associate Professor of Surgery, Weill Cornell Medical College, and a Surgeon with clinical expertise in melanoma and soft tissue sarcoma, at Memorial Sloan Kettering Cancer Center, New York, NY. Dr. Ariyan is also Section Editor, Sarcoma, at the Annals of Surgical Oncology.

Scroll to Top